HOME >> BIOLOGY >> NEWS
Colorado U. to fly hardware, experiments on space shuttle, space station

Researchers from the University of Colorado at Boulder will be flying several biomedical and agricultural experiments on NASA's space shuttle Atlantis slated for launch Oct. 2, some of which will be transferred to the International Space Station.

The CU-Boulder faculty and students involved are affiliated with BioServe Space Technologies, headquartered in the College of Engineering and Applied Science and one of several NASA centers for Space Commercialization with active space flight programs. The experiments, which will take place in sophisticated hardware and devices designed and built by BioServe engineers and students, are being undertaken in cooperation with research groups in both the public and private sectors.

Three cell biology experiments involve culturing human kidney cells, an infectious agent (salmonella), and yeast, said BioServe Director Louis Stodieck of the aerospace engineering sciences department. While culturing such cells on Earth results in the normally heavier kidney cells settling to the bottom of the medium and growing in two-dimensional sheets, culturing them in the suspended state of microgravity causes their behavior to mimic normal, functioning kidney cells.

Previous BioServe flights have documented changes in kidney cells and how the genes are expressed to produce particular proteins, said Stodieck. "Now we want to learn more about what is happening at the molecular level to control the behavior of the cells in space and on the ground.

"Ultimately we want to create 3-D models of tissues for testing new drugs that may be able to block infections," he said. "Studying how salmonella and yeast respond to microgravity will further our knowledge of molecular responses in space."

Stodieck, chief scientist on the project for BioServe, is working with three investigators from Tulane Medical University and the Louisiana Veterans Research and Education Corp. A third partne
'"/>

Contact: Stefanie Countryman
countrym@colorado.edu
303-735-5308
University of Colorado at Boulder
27-Sep-2002


Page: 1 2 3

Related biology news :

1. Colorado River Conference Aug. 26
2. Hidden cost of Colorado River diversions is $2.4 billion annually
3. Earstones tell fishes tale of early life in the Colorado River estuary
4. U. of Colorado professor pioneering tissue engineering from knees to hearts to brains
5. University of Colorado archaeologist, colleagues hot on the trail of ancient Persian warships
6. U. of Colorado team developing Flu Chip for fast, accurate diagnosis
7. Microbes active in Colorado snows fuel tundra ecosystem
8. New Colorado U. study shows increase in fungal metabolism under the snow
9. Changing global nitrogen cycle impacting human health, says Colorado University-led study
10. U. of Colorado scientists discover four new kingdoms of life
11. U.of Colorado researchers solve molecular structure involved with heart disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Colorado fly hardware experiments space shuttle space station

(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
(Date:3/4/2015)... 2015  BioClinica®, Inc., a leading specialty ... announced that clinical trial professionals representing 20 ... annual European User Conference in ... use of its eClinical technologies to overcome ... the Microsoft Office-Smart OnPoint CTMS; Express EDC; ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Reaction (PCR) represents one of the fastest growing technologies ... cell biologists in subcellular visualization is driving growth in ... need for deeper understanding of gene expressions will continue ... market. Expanding applications in fields ranging from pharma, biotech, ...
(Date:3/4/2015)... -- Lancée par l,Assistance Publique ... en décembre 2011, l,étude collaborative française randomisée et ...   l es microsphères en résine marquées ... carcinome hépatocellulaire avancé, a recruté plus de 400 ... ; les résultats sont attendus fin 2016.   ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
Cached News: